Skip to main content
Equibles

Creative Planning

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1540235 OVERLAND PARK, KS
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,816
-$3,806 QoQ
Shares Held
13,600
-0.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 130 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $457,365,908 across 219 Biotechnology names. LCTX ranks #210 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 127,672 $63,418,511
2 REGN
Regeneron Pharmaceuticals, Inc.
 36,949 $23,039,178
3 EXEL
Exelixis, Inc.
 270,292 $14,706,586
4 INCY
Incyte Corp
 110,664 $12,544,870
5 CYTK
Cytokinetics Inc
 141,939 $12,091,783
6 RVMD
Revolution Medicines, Inc.
 64,120 $12,008,393
7 ARGX
Argenx SE
 12,744 $11,823,500
8 BMRN
Biomarin Pharmaceutical Inc
 153,161 $8,763,872

All Filings in LCTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,816 13,600
2026-03-31 $21,622 13,685
2025-12-31 $30,405 18,207
2025-09-30 $30,027 17,768
2025-06-30 $12,781 14,046
2025-03-31 $5,652 12,561
2024-12-31 $12,086 24,172
2024-09-30 $21,996 24,172
2024-06-30 $24,172 24,172
2024-03-31 $38,629 26,101
2023-12-31 $28,450 26,101
2023-09-30 $33,090 28,043
2023-06-30 $43,556 30,891
2023-03-31 $46,336 30,891
2022-12-31 $30,760 26,291
2022-09-30 $29,795 26,368
2022-06-30 $41,557 26,302
2022-03-31 $39,394 25,581
2021-12-31 $57,773 23,581
2021-09-30 $64,406 25,558
2021-06-30 $71,250 25,000
2021-03-31 $273,664 116,453
2020-12-31 $204,957 116,453
2020-09-30 $109,466 116,454
2020-06-30 $120,666 138,697
2020-03-31 $87,246 105,116